Bloom Surgical, Inc. appears in FDA device records as the applicant behind a single 510(k) premarket notification, K263459, for a device named SWICS™. The submission was received September 28, 2026 and recorded as substantially equivalent on October 29, 2026 under the Traditional 510(k) pathway. The company's own website frames the product as an origami-inspired laparoscope cleaning attachment intended to clean inside the abdomen. The supplied filings document this one clearance and no other regulatory pathway. [1][3][5]
The cleared device and its regulatory record
K263459 covers SWICS™, classified under product code GCJ and regulation 21 CFR 876.1500, with the classification name Laparoscope, General & Plastic Surgery. FDA records place the device in class 2 and list the advisory committee as Gastroenterology, Urology, with the review panel recorded as General & Plastic Surgery. The decision is Substantially Equivalent (SESE), the clearance type is Traditional, and the submission included a summary rather than only a statement. [1][5][9]
The submission dates are consistent across the FDA export and third-party indexes: received September 28, 2026, decided October 29, 2026. One index describes the interval as a 31-day FDA review. The applicant contact listed in the filing is Jacob Sheffield, with an address at 15 Mario Capecchi Dr., Salt Lake City, UT 84108; that entry is a filing address, not a verified headquarters. [1][6][8]
How the company describes the technology
Bloom Surgical's website describes SWICS as a Scope Wiper & Irrigation Cleaning System and positions it as an in-abdomen rapid-response tool for intraoperative visual disruption. The stated problem is lens occlusion in minimally invasive surgery, which the company says forces full scope removal and frequent cleaning, disrupting workflow and lengthening procedures. The stated solution is an origami-inspired laparoscope cleaning attachment intended to maintain clear vision and eliminate scope removals, with cleaning performed in vivo and in situ. [3]
The site also lists affiliations and partners, including NSF, NuFund, Nucleus Institute, U Health, Ziensite, iHub and VentureWell, presented as logos without further detail in the public information. These are company-published associations; the filings do not describe them. No ownership, parent company or brand relationship is verified in the public documents. [3]
What the filing record does and does not show
The supplied collection contains one linked record, a 510(k) with a SESE decision, and the smaller record sample likewise contains that single SESE entry. These counts describe the supplied filings as of the snapshot date; they are not measures of total company portfolio, sales or safety performance. No recall records appear in the supplied sample. [1][6]
The FDA clearance letter states that the agency reviewed the section 510(k) premarket notification and determined the device substantially equivalent to legally marketed predicate devices for the indications for use stated in the enclosure. The public documents do not include those indications, clinical data, component specifications or commercial availability, so those details remain unknown here. [4][2]

